Cyclodextrin Market By Type (Alpha-Cyclodextrin, Beta-Cyclodextrin, Gamma-Cyclodextrin), By End-User Industry (Food, Pharmaceutical, Cosmetics and Personal Care, Chemical, Textile, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032
The global cyclodextrin market was valued at $334.0 million in 2022 and is estimated to reach $579.6 million by 2032, exhibiting a CAGR of 5.7% from 2023 to 2032.
Cyclodextrins are cyclic oligosaccharides composed of glucose units linked by alpha-1,4-glycosidic bonds. These molecules have a unique torus or truncated cone structure, characterized by a hydrophobic central cavity and a hydrophilic outer surface. Cyclodextrins are known for their ability to form inclusion complexes with other molecules, where the guest molecule can be encapsulated within their central cavity. This property makes cyclodextrins useful in various industries, including pharmaceuticals, food, cosmetics, and more, for applications such as improving the solubility, stability, and bioavailability of different compounds.
The growing emphasis on sustainability and green chemistry practices is another driving force for the cyclodextrin market. Cyclodextrins are biodegradable and environmentally friendly, making them attractive for applications where eco-friendly alternatives are prioritized. The use of cyclodextrins in place of traditional chemicals aligns with the global push towards sustainable practices, appealing to industries seeking environmentally conscious solutions.
Moreover, ongoing research and development activities in various industries contribute to the expansion of the cyclodextrin market. Researchers are exploring new applications and formulations that leverage the unique properties of cyclodextrins. This includes novel drug delivery systems, improved encapsulation techniques, and innovative uses in areas such as agriculture and textiles. The continuous discovery of novel applications and the development of proprietary formulations drive the demand for cyclodextrins.
However, regulatory considerations also impact the cyclodextrin market. As cyclodextrins are used in various applications, including pharmaceuticals and food products, adherence to stringent regulatory requirements is crucial. Obtaining regulatory approvals for cyclodextrin-containing products can be time-consuming and expensive. Additionally, evolving regulatory landscapes and changes in compliance standards may require continuous adaptation by manufacturers, adding a layer of complexity to the market.
On the contrary, in the food and beverage sector, cyclodextrins find applications as encapsulating agents, flavor modifiers, and stabilizers. They contribute to improved product quality, taste, and shelf life. As consumers increasingly seek healthier and more natural ingredients, cyclodextrins, with their ability to mask undesirable flavors and odors, become invaluable for food manufacturers. The trend towards clean-label products and the demand for functional foods further drive the opportunities in this market segment.
The cyclodextrin market is segmented on the basis of type, end-user industry, and region. On the basis of type, the market is categorized into alpha-cyclodextrin, beta-cyclodextrin, and gamma-cyclodextrin. On the basis of end-user industry, it is divided into food, pharmaceutical, cosmetics & personal care, chemical, textile, and others. Region-wise, the market is studied across North America, Europe, Asia-Pacific, and LAMEA.
The global cyclodextrin market profiles leading players that include Cambrex Corporation, Cayman Chemical, Wellona Pharma, Wacker Chemie AG, Cyclolab, Tocopharm Co. Limited, Roquette Frères, Midas Pharma GmbH, Ligand Pharmaceuticals Incorporated, and Cyclo Therapeutics, Inc.
Other key players involved in the manufacturing of cyclodextrin includes Zibo Qianhui biological technology co., ltd, Xi'an Deli Biochemical Industry Co., Ltd, Merck KgaA, Otto Chemie Pvt. Ltd., VIO CHEMICALS, Ashland, and TCI Chemicals Pvt. Ltd. The global cyclodextrin market report provides in-depth competitive analysis as well as profiles of these major players.
Key Benefits For Stakeholders
This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the cyclodextrin market analysis from 2022 to 2032 to identify the prevailing cyclodextrin market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the cyclodextrin market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global cyclodextrin market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Type
Alpha-Cyclodextrin
Beta-Cyclodextrin
Gamma-Cyclodextrin
By End-User Industry
Food
Pharmaceutical
Cosmetics and Personal Care
Chemical
Textile
Others
By Region
North America
U.S.
Canada
Mexico
Europe
Germany
UK
France
Spain
Italy
Rest of Europe
Asia-Pacific
China
India
Japan
South Korea
Australia
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA
Key Market Players
Cayman Chemical Company
Cambrex Corporation
Wellona Pharma Private Limited.
Wacker Chemie AG.
Cyclolab
Tocopharm Co. Limited
Roquette Freres
Midas Pharma GmbH
Ligand Pharmaceuticals Incorporated
Cyclo Therapeutics, Inc
Please Note: It will take 7-10 business days to complete the report upon order confirmation.
- CHAPTER 1: INTRODUCTION
- 1.1. Report description
- 1.2. Key market segments
- 1.3. Key benefits to the stakeholders
- 1.4. Research methodology
- 1.4.1. Primary research
- 1.4.2. Secondary research
- 1.4.3. Analyst tools and models
- CHAPTER 2: EXECUTIVE SUMMARY
- 2.1. CXO Perspective
- CHAPTER 3: MARKET OVERVIEW
- 3.1. Market definition and scope
- 3.2. Key findings
- 3.2.1. Top impacting factors
- 3.2.2. Top investment pockets
- 3.3. Porter’s five forces analysis
- 3.4. Market dynamics
- 3.4.1. Drivers
- 3.4.2. Restraints
- 3.4.3. Opportunities
- 3.5. Value Chain Analysis
- 3.6. Pricing Analysis
- 3.7. Key Regulation Analysis
- 3.8. Patent Landscape
- CHAPTER 4: CYCLODEXTRIN MARKET, BY TYPE
- 4.1. Overview
- 4.1.1. Market size and forecast
- 4.2. Alpha-Cyclodextrin
- 4.2.1. Key market trends, growth factors and opportunities
- 4.2.2. Market size and forecast, by region
- 4.2.3. Market share analysis by country
- 4.3. Beta-Cyclodextrin
- 4.3.1. Key market trends, growth factors and opportunities
- 4.3.2. Market size and forecast, by region
- 4.3.3. Market share analysis by country
- 4.4. Gamma-Cyclodextrin
- 4.4.1. Key market trends, growth factors and opportunities
- 4.4.2. Market size and forecast, by region
- 4.4.3. Market share analysis by country
- CHAPTER 5: CYCLODEXTRIN MARKET, BY END-USER INDUSTRY
- 5.1. Overview
- 5.1.1. Market size and forecast
- 5.2. Food
- 5.2.1. Key market trends, growth factors and opportunities
- 5.2.2. Market size and forecast, by region
- 5.2.3. Market share analysis by country
- 5.3. Pharmaceutical
- 5.3.1. Key market trends, growth factors and opportunities
- 5.3.2. Market size and forecast, by region
- 5.3.3. Market share analysis by country
- 5.4. Cosmetics and Personal Care
- 5.4.1. Key market trends, growth factors and opportunities
- 5.4.2. Market size and forecast, by region
- 5.4.3. Market share analysis by country
- 5.5. Chemical
- 5.5.1. Key market trends, growth factors and opportunities
- 5.5.2. Market size and forecast, by region
- 5.5.3. Market share analysis by country
- 5.6. Textile
- 5.6.1. Key market trends, growth factors and opportunities
- 5.6.2. Market size and forecast, by region
- 5.6.3. Market share analysis by country
- 5.7. Others
- 5.7.1. Key market trends, growth factors and opportunities
- 5.7.2. Market size and forecast, by region
- 5.7.3. Market share analysis by country
- CHAPTER 6: CYCLODEXTRIN MARKET, BY REGION
- 6.1. Overview
- 6.1.1. Market size and forecast By Region
- 6.2. North America
- 6.2.1. Key market trends, growth factors and opportunities
- 6.2.2. Market size and forecast, by Type
- 6.2.3. Market size and forecast, by End-User Industry
- 6.2.4. Market size and forecast, by country
- 6.2.4.1. U.S.
- 6.2.4.1.1. Market size and forecast, by Type
- 6.2.4.1.2. Market size and forecast, by End-User Industry
- 6.2.4.2. Canada
- 6.2.4.2.1. Market size and forecast, by Type
- 6.2.4.2.2. Market size and forecast, by End-User Industry
- 6.2.4.3. Mexico
- 6.2.4.3.1. Market size and forecast, by Type
- 6.2.4.3.2. Market size and forecast, by End-User Industry
- 6.3. Europe
- 6.3.1. Key market trends, growth factors and opportunities
- 6.3.2. Market size and forecast, by Type
- 6.3.3. Market size and forecast, by End-User Industry
- 6.3.4. Market size and forecast, by country
- 6.3.4.1. Germany
- 6.3.4.1.1. Market size and forecast, by Type
- 6.3.4.1.2. Market size and forecast, by End-User Industry
- 6.3.4.2. UK
- 6.3.4.2.1. Market size and forecast, by Type
- 6.3.4.2.2. Market size and forecast, by End-User Industry
- 6.3.4.3. France
- 6.3.4.3.1. Market size and forecast, by Type
- 6.3.4.3.2. Market size and forecast, by End-User Industry
- 6.3.4.4. Spain
- 6.3.4.4.1. Market size and forecast, by Type
- 6.3.4.4.2. Market size and forecast, by End-User Industry
- 6.3.4.5. Italy
- 6.3.4.5.1. Market size and forecast, by Type
- 6.3.4.5.2. Market size and forecast, by End-User Industry
- 6.3.4.6. Rest of Europe
- 6.3.4.6.1. Market size and forecast, by Type
- 6.3.4.6.2. Market size and forecast, by End-User Industry
- 6.4. Asia-Pacific
- 6.4.1. Key market trends, growth factors and opportunities
- 6.4.2. Market size and forecast, by Type
- 6.4.3. Market size and forecast, by End-User Industry
- 6.4.4. Market size and forecast, by country
- 6.4.4.1. China
- 6.4.4.1.1. Market size and forecast, by Type
- 6.4.4.1.2. Market size and forecast, by End-User Industry
- 6.4.4.2. India
- 6.4.4.2.1. Market size and forecast, by Type
- 6.4.4.2.2. Market size and forecast, by End-User Industry
- 6.4.4.3. Japan
- 6.4.4.3.1. Market size and forecast, by Type
- 6.4.4.3.2. Market size and forecast, by End-User Industry
- 6.4.4.4. South Korea
- 6.4.4.4.1. Market size and forecast, by Type
- 6.4.4.4.2. Market size and forecast, by End-User Industry
- 6.4.4.5. Australia
- 6.4.4.5.1. Market size and forecast, by Type
- 6.4.4.5.2. Market size and forecast, by End-User Industry
- 6.4.4.6. Rest of Asia-Pacific
- 6.4.4.6.1. Market size and forecast, by Type
- 6.4.4.6.2. Market size and forecast, by End-User Industry
- 6.5. LAMEA
- 6.5.1. Key market trends, growth factors and opportunities
- 6.5.2. Market size and forecast, by Type
- 6.5.3. Market size and forecast, by End-User Industry
- 6.5.4. Market size and forecast, by country
- 6.5.4.1. Brazil
- 6.5.4.1.1. Market size and forecast, by Type
- 6.5.4.1.2. Market size and forecast, by End-User Industry
- 6.5.4.2. Saudi Arabia
- 6.5.4.2.1. Market size and forecast, by Type
- 6.5.4.2.2. Market size and forecast, by End-User Industry
- 6.5.4.3. South Africa
- 6.5.4.3.1. Market size and forecast, by Type
- 6.5.4.3.2. Market size and forecast, by End-User Industry
- 6.5.4.4. Rest of LAMEA
- 6.5.4.4.1. Market size and forecast, by Type
- 6.5.4.4.2. Market size and forecast, by End-User Industry
- CHAPTER 7: COMPETITIVE LANDSCAPE
- 7.1. Introduction
- 7.2. Top winning strategies
- 7.3. Product mapping of top 10 player
- 7.4. Competitive dashboard
- 7.5. Competitive heatmap
- 7.6. Top player positioning, 2022
- CHAPTER 8: COMPANY PROFILES
- 8.1. Cayman Chemical Company
- 8.1.1. Company overview
- 8.1.2. Key executives
- 8.1.3. Company snapshot
- 8.1.4. Operating business segments
- 8.1.5. Product portfolio
- 8.1.6. Business performance
- 8.1.7. Key strategic moves and developments
- 8.2. Cambrex Corporation
- 8.2.1. Company overview
- 8.2.2. Key executives
- 8.2.3. Company snapshot
- 8.2.4. Operating business segments
- 8.2.5. Product portfolio
- 8.2.6. Business performance
- 8.2.7. Key strategic moves and developments
- 8.3. Wellona Pharma Private Limited.
- 8.3.1. Company overview
- 8.3.2. Key executives
- 8.3.3. Company snapshot
- 8.3.4. Operating business segments
- 8.3.5. Product portfolio
- 8.3.6. Business performance
- 8.3.7. Key strategic moves and developments
- 8.4. Wacker Chemie AG.
- 8.4.1. Company overview
- 8.4.2. Key executives
- 8.4.3. Company snapshot
- 8.4.4. Operating business segments
- 8.4.5. Product portfolio
- 8.4.6. Business performance
- 8.4.7. Key strategic moves and developments
- 8.5. Cyclolab
- 8.5.1. Company overview
- 8.5.2. Key executives
- 8.5.3. Company snapshot
- 8.5.4. Operating business segments
- 8.5.5. Product portfolio
- 8.5.6. Business performance
- 8.5.7. Key strategic moves and developments
- 8.6. Tocopharm Co. Limited
- 8.6.1. Company overview
- 8.6.2. Key executives
- 8.6.3. Company snapshot
- 8.6.4. Operating business segments
- 8.6.5. Product portfolio
- 8.6.6. Business performance
- 8.6.7. Key strategic moves and developments
- 8.7. Roquette Freres
- 8.7.1. Company overview
- 8.7.2. Key executives
- 8.7.3. Company snapshot
- 8.7.4. Operating business segments
- 8.7.5. Product portfolio
- 8.7.6. Business performance
- 8.7.7. Key strategic moves and developments
- 8.8. Midas Pharma GmbH
- 8.8.1. Company overview
- 8.8.2. Key executives
- 8.8.3. Company snapshot
- 8.8.4. Operating business segments
- 8.8.5. Product portfolio
- 8.8.6. Business performance
- 8.8.7. Key strategic moves and developments
- 8.9. Ligand Pharmaceuticals Incorporated
- 8.9.1. Company overview
- 8.9.2. Key executives
- 8.9.3. Company snapshot
- 8.9.4. Operating business segments
- 8.9.5. Product portfolio
- 8.9.6. Business performance
- 8.9.7. Key strategic moves and developments
- 8.10. Cyclo Therapeutics, Inc
- 8.10.1. Company overview
- 8.10.2. Key executives
- 8.10.3. Company snapshot
- 8.10.4. Operating business segments
- 8.10.5. Product portfolio
- 8.10.6. Business performance
- 8.10.7. Key strategic moves and developments
- LIST OF TABLES
- TABLE 01. GLOBAL CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 ($MILLION)
- TABLE 02. GLOBAL CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 (TONS)
- TABLE 03. CYCLODEXTRIN MARKET FOR ALPHA-CYCLODEXTRIN, BY REGION, 2022-2032 ($MILLION)
- TABLE 04. CYCLODEXTRIN MARKET FOR ALPHA-CYCLODEXTRIN, BY REGION, 2022-2032 (TONS)
- TABLE 05. CYCLODEXTRIN MARKET FOR BETA-CYCLODEXTRIN, BY REGION, 2022-2032 ($MILLION)
- TABLE 06. CYCLODEXTRIN MARKET FOR BETA-CYCLODEXTRIN, BY REGION, 2022-2032 (TONS)
- TABLE 07. CYCLODEXTRIN MARKET FOR GAMMA-CYCLODEXTRIN, BY REGION, 2022-2032 ($MILLION)
- TABLE 08. CYCLODEXTRIN MARKET FOR GAMMA-CYCLODEXTRIN, BY REGION, 2022-2032 (TONS)
- TABLE 09. GLOBAL CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 ($MILLION)
- TABLE 10. GLOBAL CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 (TONS)
- TABLE 11. CYCLODEXTRIN MARKET FOR FOOD, BY REGION, 2022-2032 ($MILLION)
- TABLE 12. CYCLODEXTRIN MARKET FOR FOOD, BY REGION, 2022-2032 (TONS)
- TABLE 13. CYCLODEXTRIN MARKET FOR PHARMACEUTICAL, BY REGION, 2022-2032 ($MILLION)
- TABLE 14. CYCLODEXTRIN MARKET FOR PHARMACEUTICAL, BY REGION, 2022-2032 (TONS)
- TABLE 15. CYCLODEXTRIN MARKET FOR COSMETICS AND PERSONAL CARE, BY REGION, 2022-2032 ($MILLION)
- TABLE 16. CYCLODEXTRIN MARKET FOR COSMETICS AND PERSONAL CARE, BY REGION, 2022-2032 (TONS)
- TABLE 17. CYCLODEXTRIN MARKET FOR CHEMICAL, BY REGION, 2022-2032 ($MILLION)
- TABLE 18. CYCLODEXTRIN MARKET FOR CHEMICAL, BY REGION, 2022-2032 (TONS)
- TABLE 19. CYCLODEXTRIN MARKET FOR TEXTILE, BY REGION, 2022-2032 ($MILLION)
- TABLE 20. CYCLODEXTRIN MARKET FOR TEXTILE, BY REGION, 2022-2032 (TONS)
- TABLE 21. CYCLODEXTRIN MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
- TABLE 22. CYCLODEXTRIN MARKET FOR OTHERS, BY REGION, 2022-2032 (TONS)
- TABLE 23. CYCLODEXTRIN MARKET, BY REGION, 2022-2032 ($MILLION)
- TABLE 24. CYCLODEXTRIN MARKET, BY REGION, 2022-2032 (TONS)
- TABLE 25. NORTH AMERICA CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 ($MILLION)
- TABLE 26. NORTH AMERICA CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 (TONS)
- TABLE 27. NORTH AMERICA CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 ($MILLION)
- TABLE 28. NORTH AMERICA CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 (TONS)
- TABLE 29. NORTH AMERICA CYCLODEXTRIN MARKET, BY COUNTRY, 2022-2032 ($MILLION)
- TABLE 30. NORTH AMERICA CYCLODEXTRIN MARKET, BY COUNTRY, 2022-2032 (TONS)
- TABLE 31. U.S. CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 ($MILLION)
- TABLE 32. U.S. CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 (TONS)
- TABLE 33. U.S. CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 ($MILLION)
- TABLE 34. U.S. CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 (TONS)
- TABLE 35. CANADA CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 ($MILLION)
- TABLE 36. CANADA CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 (TONS)
- TABLE 37. CANADA CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 ($MILLION)
- TABLE 38. CANADA CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 (TONS)
- TABLE 39. MEXICO CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 ($MILLION)
- TABLE 40. MEXICO CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 (TONS)
- TABLE 41. MEXICO CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 ($MILLION)
- TABLE 42. MEXICO CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 (TONS)
- TABLE 43. EUROPE CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 ($MILLION)
- TABLE 44. EUROPE CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 (TONS)
- TABLE 45. EUROPE CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 ($MILLION)
- TABLE 46. EUROPE CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 (TONS)
- TABLE 47. EUROPE CYCLODEXTRIN MARKET, BY COUNTRY, 2022-2032 ($MILLION)
- TABLE 48. EUROPE CYCLODEXTRIN MARKET, BY COUNTRY, 2022-2032 (TONS)
- TABLE 49. GERMANY CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 ($MILLION)
- TABLE 50. GERMANY CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 (TONS)
- TABLE 51. GERMANY CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 ($MILLION)
- TABLE 52. GERMANY CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 (TONS)
- TABLE 53. UK CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 ($MILLION)
- TABLE 54. UK CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 (TONS)
- TABLE 55. UK CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 ($MILLION)
- TABLE 56. UK CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 (TONS)
- TABLE 57. FRANCE CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 ($MILLION)
- TABLE 58. FRANCE CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 (TONS)
- TABLE 59. FRANCE CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 ($MILLION)
- TABLE 60. FRANCE CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 (TONS)
- TABLE 61. SPAIN CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 ($MILLION)
- TABLE 62. SPAIN CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 (TONS)
- TABLE 63. SPAIN CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 ($MILLION)
- TABLE 64. SPAIN CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 (TONS)
- TABLE 65. ITALY CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 ($MILLION)
- TABLE 66. ITALY CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 (TONS)
- TABLE 67. ITALY CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 ($MILLION)
- TABLE 68. ITALY CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 (TONS)
- TABLE 69. REST OF EUROPE CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 ($MILLION)
- TABLE 70. REST OF EUROPE CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 (TONS)
- TABLE 71. REST OF EUROPE CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 ($MILLION)
- TABLE 72. REST OF EUROPE CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 (TONS)
- TABLE 73. ASIA-PACIFIC CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 ($MILLION)
- TABLE 74. ASIA-PACIFIC CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 (TONS)
- TABLE 75. ASIA-PACIFIC CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 ($MILLION)
- TABLE 76. ASIA-PACIFIC CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 (TONS)
- TABLE 77. ASIA-PACIFIC CYCLODEXTRIN MARKET, BY COUNTRY, 2022-2032 ($MILLION)
- TABLE 78. ASIA-PACIFIC CYCLODEXTRIN MARKET, BY COUNTRY, 2022-2032 (TONS)
- TABLE 79. CHINA CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 ($MILLION)
- TABLE 80. CHINA CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 (TONS)
- TABLE 81. CHINA CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 ($MILLION)
- TABLE 82. CHINA CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 (TONS)
- TABLE 83. INDIA CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 ($MILLION)
- TABLE 84. INDIA CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 (TONS)
- TABLE 85. INDIA CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 ($MILLION)
- TABLE 86. INDIA CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 (TONS)
- TABLE 87. JAPAN CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 ($MILLION)
- TABLE 88. JAPAN CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 (TONS)
- TABLE 89. JAPAN CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 ($MILLION)
- TABLE 90. JAPAN CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 (TONS)
- TABLE 91. SOUTH KOREA CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 ($MILLION)
- TABLE 92. SOUTH KOREA CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 (TONS)
- TABLE 93. SOUTH KOREA CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 ($MILLION)
- TABLE 94. SOUTH KOREA CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 (TONS)
- TABLE 95. AUSTRALIA CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 ($MILLION)
- TABLE 96. AUSTRALIA CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 (TONS)
- TABLE 97. AUSTRALIA CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 ($MILLION)
- TABLE 98. AUSTRALIA CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 (TONS)
- TABLE 99. REST OF ASIA-PACIFIC CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 ($MILLION)
- TABLE 100. REST OF ASIA-PACIFIC CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 (TONS)
- TABLE 101. REST OF ASIA-PACIFIC CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 ($MILLION)
- TABLE 102. REST OF ASIA-PACIFIC CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 (TONS)
- TABLE 103. LAMEA CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 ($MILLION)
- TABLE 104. LAMEA CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 (TONS)
- TABLE 105. LAMEA CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 ($MILLION)
- TABLE 106. LAMEA CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 (TONS)
- TABLE 107. LAMEA CYCLODEXTRIN MARKET, BY COUNTRY, 2022-2032 ($MILLION)
- TABLE 108. LAMEA CYCLODEXTRIN MARKET, BY COUNTRY, 2022-2032 (TONS)
- TABLE 109. BRAZIL CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 ($MILLION)
- TABLE 110. BRAZIL CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 (TONS)
- TABLE 111. BRAZIL CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 ($MILLION)
- TABLE 112. BRAZIL CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 (TONS)
- TABLE 113. SAUDI ARABIA CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 ($MILLION)
- TABLE 114. SAUDI ARABIA CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 (TONS)
- TABLE 115. SAUDI ARABIA CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 ($MILLION)
- TABLE 116. SAUDI ARABIA CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 (TONS)
- TABLE 117. SOUTH AFRICA CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 ($MILLION)
- TABLE 118. SOUTH AFRICA CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 (TONS)
- TABLE 119. SOUTH AFRICA CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 ($MILLION)
- TABLE 120. SOUTH AFRICA CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 (TONS)
- TABLE 121. REST OF LAMEA CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 ($MILLION)
- TABLE 122. REST OF LAMEA CYCLODEXTRIN MARKET, BY TYPE, 2022-2032 (TONS)
- TABLE 123. REST OF LAMEA CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 ($MILLION)
- TABLE 124. REST OF LAMEA CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022-2032 (TONS)
- TABLE 125. CAYMAN CHEMICAL COMPANY: KEY EXECUTIVES
- TABLE 126. CAYMAN CHEMICAL COMPANY: COMPANY SNAPSHOT
- TABLE 127. CAYMAN CHEMICAL COMPANY: PRODUCT SEGMENTS
- TABLE 128. CAYMAN CHEMICAL COMPANY: SERVICE SEGMENTS
- TABLE 129. CAYMAN CHEMICAL COMPANY: PRODUCT PORTFOLIO
- TABLE 130. CAYMAN CHEMICAL COMPANY: KEY STRATERGIES
- TABLE 131. CAMBREX CORPORATION: KEY EXECUTIVES
- TABLE 132. CAMBREX CORPORATION: COMPANY SNAPSHOT
- TABLE 133. CAMBREX CORPORATION: PRODUCT SEGMENTS
- TABLE 134. CAMBREX CORPORATION: SERVICE SEGMENTS
- TABLE 135. CAMBREX CORPORATION: PRODUCT PORTFOLIO
- TABLE 136. CAMBREX CORPORATION: KEY STRATERGIES
- TABLE 137. WELLONA PHARMA PRIVATE LIMITED.: KEY EXECUTIVES
- TABLE 138. WELLONA PHARMA PRIVATE LIMITED.: COMPANY SNAPSHOT
- TABLE 139. WELLONA PHARMA PRIVATE LIMITED.: PRODUCT SEGMENTS
- TABLE 140. WELLONA PHARMA PRIVATE LIMITED.: SERVICE SEGMENTS
- TABLE 141. WELLONA PHARMA PRIVATE LIMITED.: PRODUCT PORTFOLIO
- TABLE 142. WELLONA PHARMA PRIVATE LIMITED.: KEY STRATERGIES
- TABLE 143. WACKER CHEMIE AG.: KEY EXECUTIVES
- TABLE 144. WACKER CHEMIE AG.: COMPANY SNAPSHOT
- TABLE 145. WACKER CHEMIE AG.: PRODUCT SEGMENTS
- TABLE 146. WACKER CHEMIE AG.: SERVICE SEGMENTS
- TABLE 147. WACKER CHEMIE AG.: PRODUCT PORTFOLIO
- TABLE 148. WACKER CHEMIE AG.: KEY STRATERGIES
- TABLE 149. CYCLOLAB: KEY EXECUTIVES
- TABLE 150. CYCLOLAB: COMPANY SNAPSHOT
- TABLE 151. CYCLOLAB: PRODUCT SEGMENTS
- TABLE 152. CYCLOLAB: SERVICE SEGMENTS
- TABLE 153. CYCLOLAB: PRODUCT PORTFOLIO
- TABLE 154. CYCLOLAB: KEY STRATERGIES
- TABLE 155. TOCOPHARM CO. LIMITED: KEY EXECUTIVES
- TABLE 156. TOCOPHARM CO. LIMITED: COMPANY SNAPSHOT
- TABLE 157. TOCOPHARM CO. LIMITED: PRODUCT SEGMENTS
- TABLE 158. TOCOPHARM CO. LIMITED: SERVICE SEGMENTS
- TABLE 159. TOCOPHARM CO. LIMITED: PRODUCT PORTFOLIO
- TABLE 160. TOCOPHARM CO. LIMITED: KEY STRATERGIES
- TABLE 161. ROQUETTE FRERES: KEY EXECUTIVES
- TABLE 162. ROQUETTE FRERES: COMPANY SNAPSHOT
- TABLE 163. ROQUETTE FRERES: PRODUCT SEGMENTS
- TABLE 164. ROQUETTE FRERES: SERVICE SEGMENTS
- TABLE 165. ROQUETTE FRERES: PRODUCT PORTFOLIO
- TABLE 166. ROQUETTE FRERES: KEY STRATERGIES
- TABLE 167. MIDAS PHARMA GMBH: KEY EXECUTIVES
- TABLE 168. MIDAS PHARMA GMBH: COMPANY SNAPSHOT
- TABLE 169. MIDAS PHARMA GMBH: PRODUCT SEGMENTS
- TABLE 170. MIDAS PHARMA GMBH: SERVICE SEGMENTS
- TABLE 171. MIDAS PHARMA GMBH: PRODUCT PORTFOLIO
- TABLE 172. MIDAS PHARMA GMBH: KEY STRATERGIES
- TABLE 173. LIGAND PHARMACEUTICALS INCORPORATED: KEY EXECUTIVES
- TABLE 174. LIGAND PHARMACEUTICALS INCORPORATED: COMPANY SNAPSHOT
- TABLE 175. LIGAND PHARMACEUTICALS INCORPORATED: PRODUCT SEGMENTS
- TABLE 176. LIGAND PHARMACEUTICALS INCORPORATED: SERVICE SEGMENTS
- TABLE 177. LIGAND PHARMACEUTICALS INCORPORATED: PRODUCT PORTFOLIO
- TABLE 178. LIGAND PHARMACEUTICALS INCORPORATED: KEY STRATERGIES
- TABLE 179. CYCLO THERAPEUTICS, INC: KEY EXECUTIVES
- TABLE 180. CYCLO THERAPEUTICS, INC: COMPANY SNAPSHOT
- TABLE 181. CYCLO THERAPEUTICS, INC: PRODUCT SEGMENTS
- TABLE 182. CYCLO THERAPEUTICS, INC: SERVICE SEGMENTS
- TABLE 183. CYCLO THERAPEUTICS, INC: PRODUCT PORTFOLIO
- TABLE 184. CYCLO THERAPEUTICS, INC: KEY STRATERGIES
- LIST OF FIGURES
- FIGURE 01. CYCLODEXTRIN MARKET, 2022-2032
- FIGURE 02. SEGMENTATION OF CYCLODEXTRIN MARKET,2022-2032
- FIGURE 03. TOP IMPACTING FACTORS IN CYCLODEXTRIN MARKET
- FIGURE 04. TOP INVESTMENT POCKETS IN CYCLODEXTRIN MARKET (2023-2032)
- FIGURE 05. BARGAINING POWER OF SUPPLIERS
- FIGURE 06. BARGAINING POWER OF BUYERS
- FIGURE 07. THREAT OF SUBSTITUTION
- FIGURE 08. THREAT OF SUBSTITUTION
- FIGURE 09. COMPETITIVE RIVALRY
- FIGURE 10. GLOBAL CYCLODEXTRIN MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
- FIGURE 11. PRICING ANALYSIS: CYCLODEXTRIN MARKET 2022 AND 2032
- FIGURE 12. IMPACT OF KEY REGULATION: CYCLODEXTRIN MARKET
- FIGURE 13. PATENT ANALYSIS BY COMPANY
- FIGURE 14. PATENT ANALYSIS BY COUNTRY
- FIGURE 15. CYCLODEXTRIN MARKET, BY TYPE, 2022 AND 2032(%)
- FIGURE 16. COMPARATIVE SHARE ANALYSIS OF CYCLODEXTRIN MARKET FOR ALPHA-CYCLODEXTRIN, BY COUNTRY 2022 AND 2032(%)
- FIGURE 17. COMPARATIVE SHARE ANALYSIS OF CYCLODEXTRIN MARKET FOR BETA-CYCLODEXTRIN, BY COUNTRY 2022 AND 2032(%)
- FIGURE 18. COMPARATIVE SHARE ANALYSIS OF CYCLODEXTRIN MARKET FOR GAMMA-CYCLODEXTRIN, BY COUNTRY 2022 AND 2032(%)
- FIGURE 19. CYCLODEXTRIN MARKET, BY END-USER INDUSTRY, 2022 AND 2032(%)
- FIGURE 20. COMPARATIVE SHARE ANALYSIS OF CYCLODEXTRIN MARKET FOR FOOD, BY COUNTRY 2022 AND 2032(%)
- FIGURE 21. COMPARATIVE SHARE ANALYSIS OF CYCLODEXTRIN MARKET FOR PHARMACEUTICAL, BY COUNTRY 2022 AND 2032(%)
- FIGURE 22. COMPARATIVE SHARE ANALYSIS OF CYCLODEXTRIN MARKET FOR COSMETICS AND PERSONAL CARE, BY COUNTRY 2022 AND 2032(%)
- FIGURE 23. COMPARATIVE SHARE ANALYSIS OF CYCLODEXTRIN MARKET FOR CHEMICAL, BY COUNTRY 2022 AND 2032(%)
- FIGURE 24. COMPARATIVE SHARE ANALYSIS OF CYCLODEXTRIN MARKET FOR TEXTILE, BY COUNTRY 2022 AND 2032(%)
- FIGURE 25. COMPARATIVE SHARE ANALYSIS OF CYCLODEXTRIN MARKET FOR OTHERS, BY COUNTRY 2022 AND 2032(%)
- FIGURE 26. CYCLODEXTRIN MARKET BY REGION, 2022 AND 2032(%)
- FIGURE 27. U.S. CYCLODEXTRIN MARKET, 2022-2032 ($MILLION)
- FIGURE 28. CANADA CYCLODEXTRIN MARKET, 2022-2032 ($MILLION)
- FIGURE 29. MEXICO CYCLODEXTRIN MARKET, 2022-2032 ($MILLION)
- FIGURE 30. GERMANY CYCLODEXTRIN MARKET, 2022-2032 ($MILLION)
- FIGURE 31. UK CYCLODEXTRIN MARKET, 2022-2032 ($MILLION)
- FIGURE 32. FRANCE CYCLODEXTRIN MARKET, 2022-2032 ($MILLION)
- FIGURE 33. SPAIN CYCLODEXTRIN MARKET, 2022-2032 ($MILLION)
- FIGURE 34. ITALY CYCLODEXTRIN MARKET, 2022-2032 ($MILLION)
- FIGURE 35. REST OF EUROPE CYCLODEXTRIN MARKET, 2022-2032 ($MILLION)
- FIGURE 36. CHINA CYCLODEXTRIN MARKET, 2022-2032 ($MILLION)
- FIGURE 37. INDIA CYCLODEXTRIN MARKET, 2022-2032 ($MILLION)
- FIGURE 38. JAPAN CYCLODEXTRIN MARKET, 2022-2032 ($MILLION)
- FIGURE 39. SOUTH KOREA CYCLODEXTRIN MARKET, 2022-2032 ($MILLION)
- FIGURE 40. AUSTRALIA CYCLODEXTRIN MARKET, 2022-2032 ($MILLION)
- FIGURE 41. REST OF ASIA-PACIFIC CYCLODEXTRIN MARKET, 2022-2032 ($MILLION)
- FIGURE 42. BRAZIL CYCLODEXTRIN MARKET, 2022-2032 ($MILLION)
- FIGURE 43. SAUDI ARABIA CYCLODEXTRIN MARKET, 2022-2032 ($MILLION)
- FIGURE 44. SOUTH AFRICA CYCLODEXTRIN MARKET, 2022-2032 ($MILLION)
- FIGURE 45. REST OF LAMEA CYCLODEXTRIN MARKET, 2022-2032 ($MILLION)
- FIGURE 46. TOP WINNING STRATEGIES, BY YEAR
- FIGURE 47. TOP WINNING STRATEGIES, BY DEVELOPMENT
- FIGURE 48. TOP WINNING STRATEGIES, BY COMPANY
- FIGURE 49. PRODUCT MAPPING OF TOP 10 PLAYERS
- FIGURE 50. COMPETITIVE DASHBOARD
- FIGURE 51. COMPETITIVE HEATMAP: CYCLODEXTRIN MARKET
- FIGURE 52. TOP PLAYER POSITIONING, 2022
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook